DeepMed Research

Sequenom, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1994-01-01

Employees: 501

Market Cap: -

Website: https://womenshealth.labcorp.com

Clinical Trials

Determination of Performance Characteristics of the MassPLEX Factor II/V Leiden Test

Completed

Conditions: Factor V Leiden
Factor II
Thrombosis

First Posted Date: 2013-04-19

Last Posted Date: 2014-01-20

Lead Sponsor: Sequenom, Inc.

Target Recruit Count: 867

Registration Number: NCT01835483

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
🇺🇸
Sequenom Center for Molecular Medicine, Grand Rapids, Michigan, United States
🇺🇸
The Methodist Hospital Research Institute, Houston, Texas, United States

Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)

Completed

Conditions: Choroidal Neovascular Age-related Macular Degeneration
Age-related Macular Degeneration

First Posted Date: 2012-09-10

Last Posted Date: 2014-01-20

Lead Sponsor: Sequenom, Inc.

Target Recruit Count: 45

Registration Number: NCT01682382

Locations: 🇺🇸
Morris Eye Group, Encinitas, California, United States

Genetic Load and Phenotype in Aggressive AMD

Completed

Conditions: Age-related Macular Degeneration

Interventions: Device: RetnaGene AMD LDT

First Posted Date: 2012-07-26

Last Posted Date: 2014-01-20

Lead Sponsor: Sequenom, Inc.

Target Recruit Count: 100

Registration Number: NCT01650948

Locations: 🇺🇸
Tennessee Retina, Nashville, Tennessee, United States
🇺🇸
Retina Associates of Kentucky, Lexington, Kentucky, United States
🇺🇸
Pacific Eye Associates, San Francisco, California, United States

Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients

Completed

Conditions: Age Related Macular Degeneration

First Posted Date: 2012-07-19

Last Posted Date: 2013-02-12

Lead Sponsor: Sequenom, Inc.

Target Recruit Count: 196

Registration Number: NCT01644513

Locations: 🇺🇸
Ophthalmic Consultants Boston, Boston, Massachusetts, United States

Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies

Completed

Conditions: Down Syndrome
Noninvasive Prenatal Screening
Aneuploidy

Interventions: Device: SEQureDx Trisomy Test

First Posted Date: 2012-05-11

Last Posted Date: 2016-04-20

Lead Sponsor: Sequenom, Inc.

Target Recruit Count: 3333

Registration Number: NCT01597063

Locations: 🇺🇸
Virtua Health, Voorhees, New Jersey, United States
🇺🇸
Visions Clinical Research Tuscon, Tucson, Arizona, United States
🇺🇸
University of South Alabama, Mobile, Alabama, United States

and more 21 locations

Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies

Completed

Conditions: Fetal Aneuploidy
Down Syndrome

First Posted Date: 2012-03-15

Last Posted Date: 2016-04-20

Lead Sponsor: Sequenom, Inc.

Target Recruit Count: 3062

Registration Number: NCT01555346

Locations: 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸
South Florida Perinatal, Miami, Florida, United States
🇺🇸
Obstetrix Medical Group of Washington, Inc., Seattle, Washington, United States

and more 25 locations

Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy

Recruiting

Conditions: Down Syndrome
Fetal Aneuploidy

First Posted Date: 2011-09-07

Last Posted Date: 2024-10-16

Lead Sponsor: Sequenom, Inc.

Target Recruit Count: 2000

Registration Number: NCT01429389

Locations: 🇺🇸
University of Alabama Birmingham, Birmingham, Alabama, United States
🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸
Sharp-Rees Stealy Medical Group, San Diego, California, United States

and more 11 locations

Evaluation of a Noninvasive Fetal RHD Genotyping Test

Completed

Conditions: Rhesus D Genotype

First Posted Date: 2010-01-22

Last Posted Date: 2011-09-05

Lead Sponsor: Sequenom, Inc.

Target Recruit Count: 500

Registration Number: NCT01054716

Locations: 🇺🇸
Sharp Grossmont Hospital, San Diego, California, United States
🇺🇸
Women's Health Care, Inc, San Diego, California, United States
🇺🇸
West Coast OBGYN, San Diego, California, United States

and more 2 locations

Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies

Completed

Conditions: Down Syndrome
Aneuploidy

Interventions: Other: Maternal blood draw of 30 to 50ml

First Posted Date: 2010-01-20

Last Posted Date: 2021-09-20

Lead Sponsor: Sequenom, Inc.

Target Recruit Count: 150

Registration Number: NCT01052688

Locations: 🇺🇸
Perinatal Care Associates, Phoenix, Arizona, United States
🇺🇸
IGO, San Diego, California, United States
🇺🇸
St. Joseph's Hospital and medical Center, Phoenix, Arizona, United States

and more 7 locations

Evaluation of Fetal Sex in Assisted Reproductive Technology (ART) Achieved Pregnancies

Completed

Conditions: Fetal Sex Determination

First Posted Date: 2009-11-26

Last Posted Date: 2011-09-05

Lead Sponsor: Sequenom, Inc.

Target Recruit Count: 500

Registration Number: NCT01021085

Locations: 🇺🇸
Fertility Center of Las Vegas, Las Vegas, Nevada, United States
🇺🇸
Fertility Centers of Illinois, Glenview, Illinois, United States
🇺🇸
San Diego Fertility Center, San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy